Product Details
Source
Chimeric Monoclonal Anti-Her2 Antibody, Human IgG1 is recombinantly expressed in HEK293. It consists of mouse variable regions genetically fused to human IgG1 constant domains.
Antibody Type
Recombinant Monoclonal
Clone
AM598
Isotype
Human IgG1, Kappa
Host Species
Mouse
Reactivity
Human
Specificity
This product is a specific antibody against Her2.
Application
ApplicationRecommended Use / PerformanceELISA0.2-2 μg/mLPurification
Protein A purified.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Liquid
Formulation
Supplied a 0.22 μm-filtered solution in pH 6.0, 20 mM L-Histidine, with trehalose as protectant.
Please contact us for customized product forms or formulations.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 12 months under sterile conditions.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Bioactivity-ELISA

Immobilized Human Her2, His Tag (Cat. No. HE2-H5225) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Her2 Antibody, Human IgG1 (Cat. No. HE2-M598) with a linear range of 0.06-2 ng/mL (QC tested).
Protocol
Immobilized Human Her2 (498-648), His Tag (Cat. No. HE2-H52H4) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Her2 Antibody, Human IgG1 (Cat. No. HE2-M598) with a linear range of 0.06-2 ng/mL (Routinely tested).
Protocol
Immobilized Human Her2 (S310F), His Tag (Cat. No. HE2-H52H2) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Her2 Antibody, Human IgG1 (Cat. No. HE2-M598) with a linear range of 0.06-2 ng/mL (Routinely tested).
Protocol
Immobilized Human Her2 (S310Y), His Tag (Cat. No. HE2-H52H3) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Her2 Antibody, Human IgG1 (Cat. No. HE2-M598) with a linear range of 0.06-2 ng/mL (Routinely tested).
Protocol
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
Receptor protein-tyrosine kinase erbB-2
- Category:
- Approved Drugs:
47 Details
- Drugs in Clinical Trials:
238 Details
- Highest Development Stage:
Approved
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521



















